We are live on !
Find out more
Foundry Partners Portfolio holdings
AUM
$1.89B
Turnover
15.38%
1-Year Est. Return
9.84%
This Fund
S&P 500
This Quarter Est. Return
+3.66%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.05%
10 Year Est. Return
+297.72%
AUM
$2.54B
AUM Growth
+$50.1M
(+2%)
Cap. Flow
-$2.72M
Cap. Flow % of AUM
Cap. Flow %
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
13.17%
Holding
413
New
27
Increased
170
Reduced
161
Closed
24
Avg Time Held
2.4
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$11.3M |
| 2 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$9.8M |
| 3 |
Exelon
EXC
|
+$7.33M |
| 4 |
Johnson Controls International
JCI
|
+$7.16M |
| 5 |
Gilead Sciences
GILD
|
+$7.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$19M |
| 2 |
Saic
SAIC
|
+$12.6M |
| 3 |
Nucor
NUE
|
+$10M |
| 4 |
The Aaron's Company Inc Class A
AAN.A
|
+$9.06M |
| 5 |
Fulton Financial
FULT
|
+$8.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.46% |
| 2 | Industrials | 14.89% |
| 3 | Technology | 10.8% |
| 4 | Healthcare | 9.36% |
| 5 | Consumer Discretionary | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
JPMorgan Chase
JPM
$896B
| $45.3M | 1.78% |
405,249
+2,713
| +0.7% | +$299K |
2014 Q4
18 quarters
|
|
2
Citigroup
C
$196B
| $42.4M | 1.67% |
606,093
-31,165
| -5% | -$2.09M |
2013 Q4
22 quarters
|
|
3
Johnson & Johnson
JNJ
$656B
| $39.3M | 1.55% |
282,308
+19,269
| +7% | +$2.67M |
2016 Q3
11 quarters
|
|
4
AT&T
T
$147B
| $36.4M | 1.43% |
1,436,355
+8,937
| +0.6% | +$214K |
2015 Q1
17 quarters
|
|
5
Cisco
CSCO
$377B
| $31M | 1.22% |
566,645
-83,755
| -13% | -$4.63M |
2017 Q2
8 quarters
|
|
|
6
Exelon
EXC
$48.2B
| $29.9M | 1.18% |
875,609
+207,797
| +31% | +$7.33M |
2015 Q1
17 quarters
|
|
7
Pfizer
PFE
$170B
| $29M | 1.14% |
705,718
+4,321
| +0.6% | +$172K |
2017 Q4
6 quarters
|
|
8
Verizon
VZ
$191B
| $27.5M | 1.08% |
481,450
+44,265
| +10% | +$2.55M |
2017 Q4
6 quarters
|
|
9
Capital One
COF
$125B
| $27.4M | 1.08% |
301,574
+1,850
| +0.6% | +$165K |
2014 Q2
20 quarters
|
|
10
Comcast
CMCSA
$88.6B
| $26.8M | 1.05% |
632,860
+3,950
| +0.6% | +$167K |
2018 Q4
2 quarters
|
|
11
BP
BP
$115B
| $25.8M | 1.01% |
628,335
+5,517
| +0.9% | +$231K |
2013 Q4
22 quarters
|
|
12
Old National Bancorp
ONB
$9.48B
| $25.5M | 1% |
1,535,815
+150,428
| +11% | +$2.51M |
2013 Q4
22 quarters
|
|
|
RDS.B
13
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $25.2M | 0.99% |
383,530
+150,440
| +65% | +$9.8M |
2018 Q2
4 quarters
|
|
14
Philip Morris
PM
$314B
| $25.1M | 0.99% |
320,110
+4,975
| +2% | +$411K |
2018 Q2
4 quarters
|
|
15
Hancock Whitney
HWC
$5.73B
| $24.3M | 0.96% |
606,704
+60,319
| +11% | +$2.48M |
2016 Q2
12 quarters
|
|
16
Prudential Financial
PRU
$42.2B
| $22.4M | 0.88% |
221,794
+1,300
| +0.6% | +$130K |
2013 Q4
22 quarters
|
|
17
Citizens Financial Group
CFG
$26.8B
| $21.8M | 0.86% |
617,025
+3,875
| +0.6% | +$135K |
2016 Q3
11 quarters
|
|
18
Emcor
EME
$26.1B
| $21.6M | 0.85% |
245,632
+24,275
| +11% | +$1.97M |
2015 Q3
15 quarters
|
|
19
Chevron
CVX
$415B
| $21.6M | 0.85% |
173,481
+1,150
| +0.7% | +$139K |
2015 Q2
16 quarters
|
|
|
AGN
20
DELISTED
Allergan plc
AGN
| $21.4M | 0.84% |
127,845
+1,175
| +0.9% | +$163K |
2018 Q2
4 quarters
|
|
21
Regal Rexnord
RRX
$10.7B
| $21.1M | 0.83% |
258,532
+25,492
| +11% | +$2.05M |
2016 Q2
12 quarters
|
|
22
WaFd
WAFD
$2.18B
| $20.7M | 0.81% |
591,323
+58,456
| +11% | +$1.89M |
2016 Q2
12 quarters
|
|
23
Tyson Foods
TSN
$21.1B
| $20.5M | 0.81% |
254,286
-58,985
| -19% | -$4.54M |
2013 Q4
22 quarters
|
|
24
Target
TGT
$71.8B
| $20.4M | 0.8% |
236,035
+50
| +0% | +$4.04K |
2017 Q2
8 quarters
|
|
25
PPL Corp
PPL
$27.1B
| $20M | 0.79% |
646,311
+3,925
| +0.6% | +$122K |
2014 Q4
18 quarters
|
|
Similar funds
PAME
Foundry Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Foundry Partners held 413 positions worth $2.54B, up 2% from $2.49B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Foundry Partners's Q2 2019 filing shows 27 new, 170 increased, 161 reduced and 24 closed positions. Its largest new stake was Medtronic: 123,909 shares worth $12.1M. The largest sale was Intel, an estimated $19M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.
- Foundry Partners's largest Q2 2019 buy was Medtronic: 123,909 shares worth $12.1M.
- Foundry Partners added most to Royal Dutch Shell PLC ADS Class B in Q2 2019, an estimated $9.8M increase.
- Foundry Partners's biggest Q2 2019 reduction was Intel, cutting an estimated $19M.
- Foundry Partners fully exited Saic in Q2 2019, selling an estimated $12.6M.
- Foundry Partners's ten largest holdings make up 13% of its $2.54B portfolio in Q2 2019.
- Foundry Partners opened 27 new positions and closed 24 in Q2 2019.
- Foundry Partners's portfolio value rose 2% quarter-over-quarter to $2.54B.
Based on Foundry Partners's 13F filing for Q2 2019, filed 18 Jul 2019.